BioPharma Dive - Latest News

J&J boosts US manufacturing as big pharma reshores

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Mar 21, 2025 - 17:17
 0
J&J boosts US manufacturing as big pharma reshores

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Read More

Tags:

Previous Article

AstraZeneca deepens China investment; Editas loses CFO to Dyne

Next Article

Alnylam enters the ATTR-CM drug race

Related Posts

Amgen obesity drug on hold; Regeneron sets first dividend

Amgen obesity drug on hold; Regeneron sets first dividend

Feb 9, 2025  0

Orca Bio to seek approval of T cell transplant after positive trial data

Orca Bio to seek approval of T cell transplant after po...

Mar 17, 2025  0

Regeneron gene therapy helps deaf children hear in small study

Regeneron gene therapy helps deaf children hear in smal...

Feb 25, 2025  0